Koizumi Tomomi, Komiyama Nobuyuki, Nishimura Shigeyuki
Department of Cardiovascular Medicine, Saitama International Medical Center, Saitama Medical University, Hidaka, Saitama, Japan.
Ann Vasc Dis. 2015;8(4):297-301. doi: 10.3400/avd.oa.15-00057. Epub 2015 Sep 4.
Platelet-derived growth factor (PDGF) induces matrix metalloproteinase (MMP), which is regarded as a biomarker of plaque rupture or vulnerability. The aim of this study is to investigate those interactions in human coronary arteries at the onset of ST-segment elevation myocardial infarction (STEMI).
Thirty-two patients with STEMI who underwent primary percutaneous coronary intervention (PCI) were enrolled in this study. Plasma levels of PDGF-BB and MMP-9 were measured from infarct-related artery (IRA) and from femoral artery (FA) during PCI.
Plasma levels of PDGF-BB and MMP-9 in the IRA were significantly higher than those in the FA (PDGF-BB: median 3130 pg/ml, IQR (interquartile range): 2020 to 4375 pg/ml vs. median 2605 pg/ml, IQR: 1305 to 3290 pg/ml, p <0.01, MMP-9: median 49 ng/ml, IQR: 35 to 100 ng/ml vs. median 42 ng/ml, IQR: 27 to 78 ng/ml, p = 0.04, IRA and FA, respectively).
This in vivo study demonstrated that PDGF-BB with MMP-9 seems to play a role in coronary plaque instability in acute phase of STEMI.
血小板衍生生长因子(PDGF)可诱导基质金属蛋白酶(MMP),而基质金属蛋白酶被视为斑块破裂或易损性的生物标志物。本研究旨在探讨ST段抬高型心肌梗死(STEMI)发病时人类冠状动脉中的这些相互作用。
本研究纳入了32例行直接经皮冠状动脉介入治疗(PCI)的STEMI患者。在PCI期间,测量梗死相关动脉(IRA)和股动脉(FA)中的PDGF-BB和MMP-9血浆水平。
IRA中的PDGF-BB和MMP-9血浆水平显著高于FA中的水平(PDGF-BB:中位数3130 pg/ml,四分位间距(IQR):2020至4375 pg/ml,而FA中中位数为2,605 pg/ml,IQR:1305至3290 pg/ml,p<0.01;MMP-9:中位数49 ng/ml,IQR:35至100 ng/ml,而FA中中位数为42 ng/ml,IQR:27至78 ng/ml,p = 0.04,分别为IRA和FA)。
这项体内研究表明,PDGF-BB与MMP-9似乎在STEMI急性期冠状动脉斑块不稳定中起作用。